Skip to content

Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients

Translating Muscle Anabolic Strategies Into Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02990533
Acronym
GRAMS
Enrollment
80
Registered
2016-12-13
Start date
2016-09-30
Completion date
2020-11-08
Last updated
2024-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Brief summary

The goal of this pilot study is to collect preliminary data on the feasibility and effect size of interventions to modify the physiological recovery trajectory from hospitalization in community dwelling older adults.

Detailed description

The purpose of this pilot study is to test the feasibility and effect size of interventions to modify the physiological recovery trajectory from hospitalization in community dwelling older adults.

Interventions

DRUGTestosterone
DIETARY_SUPPLEMENTProtein Supplement
OTHERPlacebo Injection
OTHERPlacebo supplement

Sponsors

The University of Texas Medical Branch, Galveston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admitted to the UTMB hospital * Aged 65 years or older * Self-reported ability (with or without the aid of an assistive device) to walk across a small room two weeks prior to hospitalization * Alert and oriented x3 by a physician on H&P. * Discharged to home at hospital discharge. Participation in the study will be terminated in those subjects not discharged to home after hospital stay.

Exclusion criteria

* A Nursing home resident or hospice care patient * Uncontrolled blood pressure (systolic \>170, or diastolic \> 100) * New onset motor disability that prevents walking at the time of baseline testing (stroke with motor disability, lower limb orthopedic dx) * End stage renal disease * AST/ALT 2.5 times above the normal limit * Recent (within 3 months) or current treatment with anabolic steroids. * History of breast or prostate cancer * Palpable prostate nodule or induration or prostate specific antigen (PSA) ≥ 4 ng/ml (PSA ≥ 3 ng/ml in men at high risk of prostate cancer) * Hematocrit ≥ 50% * Any other condition or event considered exclusionary by the PI and faculty physician

Design outcomes

Primary

MeasureTime frameDescription
Physical PerformanceChange from Baseline to 30-day FollowupShort Physical Performance Battery (SPPB) scale, 0-12 points. 0=disabled; 12=high performance

Secondary

MeasureTime frameDescription
Handgrip StrengthChange from Baseline to 30-day Followupstrength by handheld dynamometer, kg
Physical Activity LevelChange from Baseline to 30-day FollowupNumber of daily steps
30 day re-admission30 days post-dischargeReadmission within 30 days of hospital discharge

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026